Egpa on Rheumatology Digesthttps://rheumatologydigest.org/tags/egpa/Recent content in Egpa on Rheumatology DigestHugoen-usTue, 09 Jun 2026 06:00:00 +0530IL-5, Eosinophils, and IL-5 Pathway Inhibitors in EGPAhttps://rheumatologydigest.org/posts/il5-inhibitors-egpa/Tue, 09 Jun 2026 06:00:00 +0530https://rheumatologydigest.org/posts/il5-inhibitors-egpa/A 2026 narrative review of the IL-5/eosinophil axis in eosinophilic granulomatosis with polyangiitis (EGPA) and the two approved IL-5 pathway inhibitors — mepolizumab and benralizumab — covering their mechanisms, MIRRA and MANDARA trial evidence, real-world data, guideline positioning, and the remaining unmet needs.